Appili Therapeutics Usa Inc.

Appili Therapeutics is a biopharmaceutical company developing drugs for infectious diseases and biodefense, with a pipeline that includes LIKMEZ (an oral metronidazole suspension for anaerobic infections), ATI-1701 (a live-attenuated vaccine for tularemia), and ATI-1801 (a topical antiparasitic for skin infections). The company pursues active partnering and in-licensing efforts to expand its clinical programs and accelerate commercialization.